Clinical Trial Update: Comparison Between Two Methods of Bilateral Stenting for Malignant Hilar Obstruction [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating two methods of bilateral stenting for malignant hilar obstruction has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cholangiocarcinoma
• Obstructive Jaundice

Snippet

Sponsor: Samsung Medical Center | Conditions: Bile Duct Neoplasm, Obstructive Jaundice | Phase 3 | Status: WITHDRAWN